Ana Stegic

Ana Stegic is a declared insider of Antibe Therapeutics Inc., with filings sourced from SEDI. Over a trading history stretching from 1 November 2021 to 15 November 2023, the count stands at 7 filings.

On the market, this insider has only ever bought: 3 purchases, €17k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 option exercises.

Half of the purchases are above €1,679 and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The record was last updated on 18 November 2023 with an option exercise (€1,163) in Antibe Therapeutics Inc. The last purchase on record was published on 10 May 2022, which is 1,629 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.